N/A
Manufactured by Cosette Pharmaceuticals, Inc.
19,165 FDA adverse event reports analyzed
Last updated: 2026-04-14
COLESEVELAM HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Cosette Pharmaceuticals, Inc.. The most commonly reported adverse reactions for COLESEVELAM HYDROCHLORIDE include OFF LABEL USE, NO ADVERSE EVENT, DIARRHOEA, NAUSEA, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for COLESEVELAM HYDROCHLORIDE.
Out of 9,095 classified reports for COLESEVELAM HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 19,165 FDA FAERS reports that mention COLESEVELAM HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include OFF LABEL USE, NO ADVERSE EVENT, DIARRHOEA, NAUSEA, FATIGUE, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Cosette Pharmaceuticals, Inc. in connection with COLESEVELAM HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.